CIK 0000744452 · Non-accelerated filer<br>Smaller reporting company
BNB PLUS CORP.
Sign in to watch- Ticker
- BNBX
- Exchange
- OTC
- Industry
- Finance Services
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 592262718
- Phone
- 631-240-8800
- Business address
- 25 HEALTH SCIENCES DRIVE, STONY BROOK, NY
- Former names
- APPLIED DNA SCIENCES INC, PROHEALTH MEDICAL TECHNOLOGIES INC, DCC ACQUISITION CORP, DATALINK CAPITAL CORP/TX/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-22 | Montgomery William W 10% owner | Purchase | +60,000 | $0.44 | $27K | 5,090,900 |
| 2019-01-18 | Montgomery William W 10% owner | Purchase | +100,000 | $0.44 | $44K | 5,030,900 |
| 2019-01-07 | Montgomery William W 10% owner | Purchase | +216,000 | $0.47 | $101K | 4,930,900 |
| 2019-01-03 | Montgomery William W 10% owner | Purchase | +154,000 | $0.44 | $67K | 4,714,900 |
| 2018-12-31 | Montgomery William W 10% owner | Purchase | +30,000 | $0.37 | $11K | 4,560,900 |
| 2018-12-10 | Jantzen Beth Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −4,167 | 0 | ||
| 2018-12-10 | Jantzen Beth Chief Financial Officer | Grant or award · Stock Option (right to buy) | +4,167 | 4,167 | ||
| 2018-12-10 | Murrah Judith Chief Information Officer | Returned to the company · Stock Option (right to buy) | −4,167 | 0 | ||
| 2018-12-10 | Murrah Judith Chief Information Officer | Grant or award · Stock Option (right to buy) | +4,167 | 4,167 | ||
| 2018-12-02 | Murrah Judith Chief Information Officer | Returned to the company · Stock Option (right to buy) | −33,334 | 0 | ||
| 2018-12-02 | Murrah Judith Chief Information Officer | Grant or award · Stock Option (right to buy) | +33,334 | 33,334 | ||
| 2018-11-29 | Hayward James A Chief Executive Officer | Conversion · Secured Convertible Note | −500,000 | 500,000 | ||
| 2018-11-29 | Jantzen Beth Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −4,167 | 0 | ||
| 2018-11-29 | Jantzen Beth Chief Financial Officer | Grant or award · Stock Option (right to buy) | +4,167 | 4,167 | ||
| 2018-10-17 | Simon Sanford R Director | Returned to the company · Stock Option (right to buy) | −11,112 | 0 | ||
| 2018-10-17 | Simon Sanford R Director | Grant or award · Stock Option (right to buy) | +11,112 | 11,112 | ||
| 2018-10-17 | SHAMASH YACOV A Director | Returned to the company · Stock Option (right to buy) | −15,186 | 0 | ||
| 2018-10-17 | SHAMASH YACOV A Director | Grant or award · Stock Option (right to buy) | +15,186 | 15,186 | ||
| 2018-10-17 | Hayward James A Chairman, CEO and President | Returned to the company · Stock Option (right to buy) | −833,334 | 0 | ||
| 2018-10-17 | Hayward James A Chairman, CEO and President | Grant or award · Stock Option (right to buy) | +833,334 | 833,334 |
Page 8 of 18 · 354 trades